Abstract
Oncologists and surgeons managing patients with colorectal cancer need to appreciate that approximately 60% of their patients are N70 years of age, more than 40% are N75 years and that these proportions may increase further in the future. Many of these patients will have co-morbidity and frailty issues. In an era of increased availability of anti-tumoural agents and expanding treatment strategies, elderly patients present a challenging therapeutic scenario. What may be considered “standard” management for the general population does not necessarily apply to this group where evidence-based data are lacking. It is against this backdrop that SIOG convened a task force meeting to review and update their existing recommendations for the treatment of elderly patients with colorectal cancer published in 2009. This necessitated review of the recent data on epidemiology, geriatric assessment as it relates to surgery and oncology, and the ability of older CRC patients to tolerate surgery, adjuvant chemotherapy, treatment of their metastatic disease including palliative chemotherapy with and without the use of the biologics, and finally the use of adjuvant and palliative radiotherapy in the treatment of older rectal cancer patients. Disclosure of interest: None declared
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.